We are live on
!
Find out more
CS
Credit Suisse Portfolio holdings
AUM
$104B
1-Year Est. Return
34.76%
This Fund
S&P 500
This Quarter
Est. Return
+8.83%
1 Year Est. Return
+34.76%
3 Year Est. Return
+49.35%
5 Year Est. Return
+181.01%
10 Year Est. Return
+395.52%
AUM
$188B
AUM Growth
+$6.54B
(+3.6%)
Cap. Flow
-$6.74B
Cap. Flow
% of AUM
-3.58%
Top 10 Holdings %
Top 10 Hldgs %
16.94%
Holding
4,804
New
439
Increased
1,801
Reduced
1,889
Closed
333
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Linde
LIN
|
+$387M |
| 2 |
iShares China Large-Cap ETF
FXI
|
+$183M |
| 3 |
iShares MSCI Brazil ETF
EWZ
|
+$144M |
| 4 |
Zai Lab
ZLAB
|
+$123M |
| 5 |
Halliburton
HAL
|
+$115M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$832M |
| 2 |
Alibaba
BABA
|
+$374M |
| 3 |
Microsoft
MSFT
|
+$321M |
| 4 |
Apple
AAPL
|
+$273M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$262M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.74% |
| 2 | Healthcare | 10.34% |
| 3 | Financials | 8.3% |
| 4 | Consumer Discretionary | 7.2% |
| 5 | Communication Services | 5.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3926
OneSpan
OSPN
$604M
| $341K | ﹤0.01% |
20,090
-1,105
| -5% | -$20.6K |
|
|
DCPH
3927
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $341K | ﹤0.01% |
34,975
+404
| +1% | +$7.6K |
|
3928
ProShares Smart Materials ETF
TINT
$2.04M
| $340K | ﹤0.01% |
+8,203
| New | +$335K |
|
|
DOMA
3929
DELISTED
Doma Holdings, Inc.
DOMA
| $340K | ﹤0.01% |
2,681
+2,244
| +514% | +$347K |
|
|
BNT
3930
Brookfield Wealth Solutions
BNT
$12.3B
| $339K | ﹤0.01% |
8,130
-3,012
| -27% | -$121K |
|
3931
Rigel Pharmaceuticals
RIGL
$749M
| $338K | ﹤0.01% |
12,775
+377
| +3% | +$11.4K |
|
|
TRHC
3932
DELISTED
Tabula Rasa HealthCare, Inc. Common Stock
TRHC
| $338K | ﹤0.01% |
22,566
-494,765
| -96% | -$9.01M |
|
|
CIR
3933
DELISTED
CIRCOR International, Inc
CIR
| $338K | ﹤0.01% |
12,409
+459
| +4% | +$14K |
|
3934
Ecovyst
ECVT
$1.25B
| $337K | ﹤0.01% |
32,854
+3,333
| +11% | +$36.5K |
|
3935
i3 Verticals
IIIV
$439M
| $337K | ﹤0.01% |
14,819
+1,615
| +12% | +$36.2K |
|
3936
Mercer International
MERC
$45.3M
| $337K | ﹤0.01% |
28,107
-2,615
| -9% | -$29K |
|
|
ORLA
3937
DELISTED
Orla Mining
ORLA
| $337K | ﹤0.01% |
88,316
-4,761
| -5% | -$18.1K |
|
3938
Axogen
AXGN
$2.43B
| $335K | ﹤0.01% |
35,738
-2,801
| -7% | -$33.6K |
|
3939
Vuzix
VUZI
$213M
| $335K | ﹤0.01% |
38,637
+3,060
| +9% | +$33.1K |
|
3940
Atlanticus Holdings
ATLC
$1.68B
| $334K | ﹤0.01% |
+4,685
| New | +$313K |
|
3941
UWM Holdings
UWMC
$624M
| $334K | ﹤0.01% |
56,637
-8,940
| -14% | -$60.3K |
|
3942
Expro Ltd
XPRO
$1.83B
| $334K | ﹤0.01% |
+23,302
| New | +$382K |
|
3943
Fulcrum Therapeutics
FULC
$288M
| $332K | ﹤0.01% |
+18,752
| New | +$371K |
|
3944
Playboy Inc
PLBY
$134M
| $332K | ﹤0.01% |
12,438
+470
| +4% | +$14.2K |
|
3945
Willdan Group
WLDN
$1.12B
| $332K | ﹤0.01% |
9,455
+292
| +3% | +$10.9K |
|
|
LCI
3946
DELISTED
Lannett Company, Inc.
LCI
| $332K | ﹤0.01% |
51,201
-4,041
| -7% | -$34.6K |
|
3947
4D Molecular Therapeutics
FDMT
$537M
| $329K | ﹤0.01% |
14,968
+6,023
| +67% | +$148K |
|
3948
Vanguard FTSE Pacific ETF
VPL
$8.37B
| $329K | ﹤0.01% |
4,218
+687
| +19% | +$54.9K |
|
3949
Alignment Healthcare
ALHC
$2.84B
| $327K | ﹤0.01% |
+23,264
| New | +$407K |
|
3950
ARKO Corp
ARKO
$826M
| $327K | ﹤0.01% |
37,316
+7,390
| +25% | +$70.8K |
|
Similar funds
CSIA
CAN
VAM
CA
MNG
DPAM
ICG
CW
Credit Suisse's Q4 2021 Portfolio in Review
As of Q4 2021, Credit Suisse held 4,804 positions worth $188B, up 3.6% from $182B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Credit Suisse withdrew a net $6.74B in Q4 2021, closing 333 positions and reducing 1,889 holdings. Its most notable exit was Kansas City Southern, an estimated $126M position sold in full.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Credit Suisse opened a new position in Bank of America Series L worth $48.1M.
- Credit Suisse's largest Q4 2021 buy was Bank of America Series L: 33,252 shares worth $48.1M.
- Credit Suisse added most to Linde in Q4 2021, an estimated $387M increase.
- Credit Suisse's biggest Q4 2021 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $832M.
- Credit Suisse fully exited Kansas City Southern in Q4 2021, selling an estimated $126M.
- Credit Suisse's ten largest holdings make up 17% of its $188B portfolio in Q4 2021.
- Credit Suisse opened 439 new positions and closed 333 in Q4 2021.
- Credit Suisse's portfolio value rose 3.6% quarter-over-quarter to $188B.
Based on Credit Suisse's 13F filing for Q4 2021, filed 14 Feb 2022.